Antiplatelet Therapy in Cardiovascular Disease (Q168211): Difference between revisions

Revision as of 14:15, 30 August 2024

Preventing cardiovascular events with medications that stop platelets from clotting.

Language	Label	Description	Also known as
English	Antiplatelet Therapy in Cardiovascular Disease	Preventing cardiovascular events with medications that stop platelets from clotting.	Aspirin Clopidogrel Ticagrelor Platelet Reactivity Cardiovascular Events Percutaneous Coronary Intervention Genetic Polymorphisms Bleeding Risk Thrombotic Events CYP2C19 Genotype

0 references

0 references

Revision as of 14:17, 24 May 2024 Sky (talk \| contribs) (‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)		Revision as of 14:15, 30 August 2024 Sky (talk \| contribs) (‎Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1) Newer edit →
description / en		description / en
	~~This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of~~ cardiovascular events~~, especially in the context of percutaneous coronary intervention~~		Preventing cardiovascular events with medications that stop platelets from clotting.